Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1141460]Researchers: A/Pr Andrew Wei (Principal investigator)
Brief description Five-year survival in acute myeloid leukaemia (AML) is only 27%, placing it amongst the worst-ranked cancers for clinical outcome. Improved patient outcomes will be achieved through implementation of a Translational Research Program to support novel agent drug testing, early-phase and randomised clinical trials and a national clinical registry to audit outcomes. New insights into leukaemic stem cell function and mechanisms of drug resistance will inform the design of future clinical trials.
Funding Amount $AUD 418,192.85
Funding Scheme Practitioner Fellowships
Notes Practitioner Fellowship
- nhmrc : 1141460
- PURL : https://purl.org/au-research/grants/nhmrc/1141460
